Biktarvy
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
61958-2505 -
Package NDC
61958-2505-1 -
Application number
NDA210251 -
SPL ID
261dcc2a-c849-46b1-abf6-4981ed2c60bc -
SPL set ID
664cb8f0-1f65-441b-b0d9-ba3d798be309 -
UNII
4L5MP1Y7W7 -
UNII
FWF6Q91TZO -
UNII
G70B4ETF4S -
RxCUI
1999667 -
RxCUI
1999673 -
RxCUI
2584354 -
RxCUI
2584356
What the source publishes
- Labeler
- Gilead Sciences, Inc.
- Active ingredients
- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- Biktarvy
- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- BICTEGRAVIR SODIUM
- EMTRICITABINE
- TENOFOVIR ALAFENAMIDE FUMARATE
Complete source data
{
"name": "Biktarvy",
"splId": "261dcc2a-c849-46b1-abf6-4981ed2c60bc",
"labels": [
{
"setId": "664cb8f0-1f65-441b-b0d9-ba3d798be309",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=664cb8f0-1f65-441b-b0d9-ba3d798be309",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=664cb8f0-1f65-441b-b0d9-ba3d798be309"
}
],
"routes": [
"ORAL"
],
"labeler": "Gilead Sciences, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2505-1)",
"package_ndc": "61958-2505-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20211007"
}
],
"productId": "61958-2505_261dcc2a-c849-46b1-abf6-4981ed2c60bc",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "61958-2505",
"deaSchedule": null,
"genericName": "bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BICTEGRAVIR SODIUM",
"strength": "30 mg/1"
},
{
"name": "EMTRICITABINE",
"strength": "120 mg/1"
},
{
"name": "TENOFOVIR ALAFENAMIDE FUMARATE",
"strength": "15 mg/1"
}
],
"applicationNumber": "NDA210251",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20211007",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175462",
"M0015066",
"N0000009947"
],
"unii": [
"4L5MP1Y7W7",
"FWF6Q91TZO",
"G70B4ETF4S"
],
"rxcui": [
"1999667",
"1999673",
"2584354",
"2584356"
],
"spl_set_id": [
"664cb8f0-1f65-441b-b0d9-ba3d798be309"
],
"pharm_class_cs": [
"Nucleosides [CS]"
],
"pharm_class_epc": [
"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleoside Reverse Transcriptase Inhibitors [MoA]"
],
"manufacturer_name": [
"Gilead Sciences, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:61958-2505_261dcc2a-c849-46b1-abf6-4981ed2c60bc"